Other Neurology, biomanufacturing start-ups bag UK AI funding PharmaphorumThe first recipients of the UK government's 500 million Sovereign AI fund have been announced, including two life sciences-focused start-ups.OtherNeuroscienceRead full story pharminent April 22, 2026 (Last updated: April 22, 2026) Pharmaphorum The first recipients of the UK government’s 500 million Sovereign AI fund have been announced, including two life sciences-focused start-ups. OtherNeuroscienceRead full story Post navigation Previous: Ionis’ antisense drug stabilizes ultra-rare disease ahead of FDA decisionNext: Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients Related Stories Other Takeda and Weave Bio collaborate on AI-driven automation in drug development pharminent September 2, 2026 Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026